CNTN2 and neoplasm: This term denotes tumour drivers derived from viral sequences integrated in the host genome, such as the promoter-enhancer in a retroviral LTR or a gene product encoded by the viral nucleic acid (e.g. HTLV-1 Tax protein or HBZ mRNA, or HPV E6 and E7 proteins).